维普中文期刊产品整合服务
48篇 您的检索式:期刊名="Vet Comp Oncol"
    题名 作者 年代 出处 被引量
1Epithelial‐mesenchymal transition as a fundamental mechanism underlying the cancer phenotype显示文摘A. Cervantes-Arias L. Y. Pang D. J. Argyle 2013Vet Comp Oncol2013,,3:1
2Cytogenetic studies in peripheral blood of bovines afflicted by pap- illomatosis显示文摘Melo T C Diniz N Campos S R et ai 2011Vet Comp Oncol2011,9,4:1
3Papillomavirus and disease in humans and animals显示文摘Campo M S 2003Vet Comp Oncol2003,1,1:1
4Cytogenetic studies in peripheral blood of bovines afflicted by pap- illomatosis显示文摘Melo T C Diniz N Campos S R 2011Vet Comp Oncol2011,9,4:1
5Hypoxia-inducible factor s-regulation,role and comparative aspects in tumourigenesis显示文摘Hansen AE Kriatensen AT Law I 2011Vet Comp Oncol2011,9,1:1
6DNA methylation and targeted sequencing of methyltransferases family genes in canine acute my- eloid leukaemia, modelling human myeloid leukaemia显示文摘Bronzini I Aresu L Paganin M 2016Vet Comp Oncol2016,4,21:1
7Canine transmissible venereal tumour: a review显示文摘B. Ganguly U. Das A. K. Das 2016Vet Comp Oncol2016,,1:1
8Treatment of feline mammary tumours using chemotherapy, surgery and a COX-2 inhibitor drug (meloxicam) : a retrospective study of 23 cases 显示文摘Borrego JF Cartagena JC Engel J 2009Vet Comp Oncol2009,7,4:1
9Safety of concurrent administration of dexrazoxane and doxorubicin in the canine canc- er patient显示文摘FitzPatrick WM Dervisis NG Kitchell BE 2010Vet Comp Oncol2010,8,4:1
10Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma显示文摘Shoeneman JK Ehrhart EJ 3rd Charles JB 2014Vet Comp Oncol2014,6,12:1
11Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs 显示文摘Fulkerson CM Dhawan D Jones DR 2015Vet Comp Oncol2015,10,:1
12comparative aspects of the pro- liferation marker thymidine kinase 1 in human and canine turnout diseases显示文摘Von euler H Eriksson S 2011Vet Comp Oncol2011,9,1:1
13European consen- sus document on mast cell tumors in dogs and eats显示文摘Blackwood L Murphy S Buracco P 2012Vet Comp Oncol2012,,:1
14Cisplatin: a review of toxicities and therapeutic applications显示文摘Barabas K Milner R Lurie D 2008Vet Comp Oncol2008,6,1:1
15European consen- sus document on mast cell tumors in dogs and cats显示文摘Blackwood L Murphy S Buracco P 2012Vet Comp Oncol2012,10,3:1
16Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcoma显示文摘Thamm DH O'Brien MG Vail DM 2008Vet Comp Oncol2008,6,2:1
17Breed inci-dence of lymphoma in a UK population of insured dogs显示文摘Edwards O S Henley W E Harding E F 2003Vet Comp Oncol(1)2003,,:1
18COX - 2, mPGES - 1 andEP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours显示文摘Millanta F Asproni P Canale A 2012Vet Comp Oncol2012,147,23:1
19Safety of concurrentadministration of dexrazoxane and doxorubiein in the caninecancer patient显示文摘FitzPatrick WM Dervisis NG Kitchell BE 2010Vet Comp Oncol2010,8,4:1
20Development and characteriza- tion of monoclonal antibodies to subgroup A avian leukosis virus显示文摘QIU Y LI X FU L 2014Vet Comp Oncol2014,12,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费